Honghua Yan

发表

Suppression of Androgen Receptor (AR)-ACE2/TMPRSS2 Axis by AR Antagonists May Be Therapeutically Beneficial for Male COVID-19 Patients

Yifeng Zhou, Jianfei Yang, Qianxiang Zhou, 2020 .

Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer

Huiping Li, Qianxiang Zhou, Qiaoxia Zhou, 2021, Breast Cancer Research and Treatment.

Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response

A. Chinnaiyan, Xuhong Cao, J. Qin, 2023, Proceedings of the National Academy of Sciences of the United States of America.

Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer.

J. Hou, Qianxiang Zhou, S. Ren, 2020, European journal of cancer.